Stuart A. Nicklin

8.4k total citations · 1 hit paper
94 papers, 4.8k citations indexed

About

Stuart A. Nicklin is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Stuart A. Nicklin has authored 94 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 59 papers in Genetics and 25 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Stuart A. Nicklin's work include Virus-based gene therapy research (58 papers), Viral Infectious Diseases and Gene Expression in Insects (33 papers) and RNA Interference and Gene Delivery (29 papers). Stuart A. Nicklin is often cited by papers focused on Virus-based gene therapy research (58 papers), Viral Infectious Diseases and Gene Expression in Insects (33 papers) and RNA Interference and Gene Delivery (29 papers). Stuart A. Nicklin collaborates with scholars based in United Kingdom, United States and Netherlands. Stuart A. Nicklin's co-authors include Andrew H. Baker, Alan L. Parker, Stephen J. White, Laura Denby, John H. McVey, Lorraine M. Work, Graeme Milligan, Simon N. Waddington, Michael Hallek and Suzanne M. K. Buckley and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Circulation.

In The Last Decade

Stuart A. Nicklin

94 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer

2008 500 citations Simon N. Waddington, John H. McVey et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart A. Nicklin United Kingdom	40	3.3k	2.9k	1.2k	757	626	94	4.8k
Alena Lizonová United States	20	1.6k 0.5×	1.6k 0.6×	725 0.6×	441 0.6×	354 0.6×	41	3.0k
Xiangwei Xiao United States	36	3.1k 0.9×	3.3k 1.2×	609 0.5×	382 0.5×	362 0.6×	96	5.6k
Michaela Scherr Germany	36	3.3k 1.0×	704 0.2×	654 0.5×	615 0.8×	128 0.2×	111	5.5k
Maxwell P. Lee United States	33	3.8k 1.2×	1.3k 0.5×	778 0.6×	196 0.3×	84 0.1×	89	4.9k
George Aslanidi United States	26	1.6k 0.5×	1.4k 0.5×	317 0.3×	212 0.3×	222 0.4×	60	2.3k
J. Yun Tso United States	28	2.1k 0.6×	548 0.2×	616 0.5×	152 0.2×	171 0.3×	51	4.3k
Giuseppe Giannini Italy	36	2.7k 0.8×	535 0.2×	820 0.7×	178 0.2×	89 0.1×	109	4.1k
Irwin H. Gelman United States	41	2.7k 0.8×	518 0.2×	735 0.6×	141 0.2×	134 0.2×	109	4.6k
Gaetano Romano United States	27	2.1k 0.6×	704 0.2×	723 0.6×	68 0.1×	146 0.2×	80	3.3k
Minna U. Kaikkonen Finland	33	4.0k 1.2×	705 0.2×	388 0.3×	167 0.2×	84 0.1×	107	5.5k

Countries citing papers authored by Stuart A. Nicklin

Since Specialization

Citations

This map shows the geographic impact of Stuart A. Nicklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart A. Nicklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart A. Nicklin more than expected).

Fields of papers citing papers by Stuart A. Nicklin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart A. Nicklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart A. Nicklin. The network helps show where Stuart A. Nicklin may publish in the future.

Co-authorship network of co-authors of Stuart A. Nicklin

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart A. Nicklin. A scholar is included among the top collaborators of Stuart A. Nicklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart A. Nicklin. Stuart A. Nicklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graham, Delyth, et al.. (2024). Unscheduled changes in pre-clinical stroke model housing contributes to variance in physiological and behavioural data outcomes: A post hoc analysis. PubMed. 8. 1522983830–1522983830. 1 indexed citations

Jenkins, Laura, Amlan Ganguly, Adrian J. Butcher, et al.. (2022). Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. Journal of Biological Chemistry. 298(3). 101655–101655. 18 indexed citations

Schwartze, Julian Tristan, Menzo Havenga, Wilfried A.M. Bakker, Angela C. Bradshaw, & Stuart A. Nicklin. (2022). Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective. Journal of Molecular Medicine. 100(6). 875–901. 24 indexed citations

Bates, Emily A., John R. Counsell, Alexander T. Baker, et al.. (2021). In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications. Viruses. 13(8). 1483–1483. 6 indexed citations

Martin, Tamara P., et al.. (2021). Preclinical models of myocardial infarction: from mechanism to translation. British Journal of Pharmacology. 179(5). 770–791. 38 indexed citations

Riddell, Alexandra, Martin McBride, Thomas Braun, et al.. (2020). RUNX1: an emerging therapeutic target for cardiovascular disease. Cardiovascular Research. 116(8). 1410–1423. 58 indexed citations

Mercer, John R., et al.. (2020). Extracellular vesicle signalling in atherosclerosis. Cellular Signalling. 75. 109751–109751. 37 indexed citations

Reid, Emma, et al.. (2019). Assessing the effects of Ang-(1-7) therapy following transient middle cerebral artery occlusion. Scientific Reports. 9(1). 3154–3154. 12 indexed citations

Riddell, Alexandra, et al.. (2019). Regulation of connexin 43 by interleukin 1β in adult rat cardiac fibroblasts and effects in an adult rat cardiac myocyte: fibroblast co-culture model. Heliyon. 6(1). e03031–e03031. 6 indexed citations

10.

Dakin, Rachel, Alan L. Parker, Christian Delles, Stuart A. Nicklin, & Andrew H. Baker. (2015). Efficient Transduction of Primary Vascular Cells by the Rare Adenovirus Serotype 49 Vector. Human Gene Therapy. 26(5). 312–319. 23 indexed citations

11.

Parker, Alan L., Angela C. Bradshaw, Raúl Alba, Stuart A. Nicklin, & Andrew H. Baker. (2013). Capsid Modification Strategies for Detargeting Adenoviral Vectors. Methods in molecular biology. 1089. 45–59. 1 indexed citations

12.

Alba, Raúl, Andrew H. Baker, & Stuart A. Nicklin. (2012). Vector Systems for Prenatal Gene Therapy: Principles of Adenovirus Design and Production. Methods in molecular biology. 891. 55–84. 11 indexed citations

13.

Masson, Rachel, Stuart A. Nicklin, Martin McBride, et al.. (2009). Onset of Experimental Severe Cardiac Fibrosis Is Mediated by Overexpression of Angiotensin-Converting Enzyme 2. Hypertension. 53(4). 694–700. 35 indexed citations

14.

Parker, Alan L., Simon N. Waddington, Suzanne M. K. Buckley, et al.. (2008). Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer. Journal of Virology. 83(1). 479–483. 66 indexed citations

15.

Waddington, Simon N., John H. McVey, David Bhella, et al.. (2008). A critical role for the adenovirus serotype 5 hexon in liver gene transfer. Human Gene Therapy. 1 indexed citations

16.

Waddington, Simon N., John H. McVey, David Bhella, et al.. (2008). Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer. Cell. 132(3). 397–409. 500 indexed citations breakdown →

17.

Parker, Alan L., Kerry D. Fisher, David Oupický, et al.. (2005). Enhanced gene transfer activity of peptide-targeted gene-delivery vectors. Journal of drug targeting. 13(1). 39–51. 36 indexed citations

18.

Denby, Laura, Stuart A. Nicklin, & Andrew H. Baker. (2005). Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation. Gene Therapy. 12(20). 1534–1538. 56 indexed citations

19.

Nicklin, Stuart A., Paul N. Reynolds, M. Julia Brosnan, et al.. (2001). Analysis of Cell-Specific Promoters for Viral Gene Therapy Targeted at the Vascular Endothelium. Hypertension. 38(1). 65–70. 61 indexed citations

20.

Nicklin, Stuart A., Mahesh de Alwis, Anne Girod, et al.. (2001). Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells. Molecular Therapy. 4(3). 174–181. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact